These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 36482612)
1. The chronological changes in the seroprevalence of anti-hepatitis A virus IgG from 2005 to 2019: Experience at four centers in the capital area of South Korea. Lim DH; Sohn W; Jeong JY; Oh H; Lee JG; Yoon EL; Kim TY; Nam S; Sohn JH Medicine (Baltimore); 2022 Dec; 101(48):e31639. PubMed ID: 36482612 [TBL] [Abstract][Full Text] [Related]
2. Changes in the seroprevalence of IgG anti-hepatitis A virus between 2001 and 2013: experience at a single center in Korea. Chung SJ; Kim TY; Kim SM; Roh M; Yu MY; Lee JH; Oh C; Lee EY; Lee S; Jeon YC; Yoo KS; Sohn JH Clin Mol Hepatol; 2014 Jun; 20(2):162-7. PubMed ID: 25032182 [TBL] [Abstract][Full Text] [Related]
3. [The seroprevalence rate, vaccination rate and seroconversion rate of hepatitis A in central region of Korea]. Yun SW; Lee WK; Cho SY; Moon SH; Shin HD; Yun SY; Kim SB; Shin JE; Kim HJ; Song IH; Lee KS; Lee JH Korean J Gastroenterol; 2011 Mar; 57(3):166-72. PubMed ID: 21519164 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of IgG anti-HAV in patients with chronic hepatitis B and in the general healthy population in Korea. Lee SH; Kim HS; Park KO; Park JW; Chun SY; Lim SJ; Cho HJ; Kim SJ; Park HW; Moon HK; Shin WG; Kim KH; Jang MK; Lee JH; Kim HY Korean J Hepatol; 2010 Dec; 16(4):362-8. PubMed ID: 21415579 [TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of anti-HAV among patients with chronic viral liver disease. Cho HC; Paik SW; Kim YJ; Choi MS; Lee JH; Koh KC; Yoo BC; Son HJ; Kim SW World J Gastroenterol; 2011 Jan; 17(2):236-41. PubMed ID: 21245998 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis A seroprevalence in Erzurum, Turkey. Yilmaz A Ann Agric Environ Med; 2020 Sep; 27(3):481-484. PubMed ID: 32955233 [TBL] [Abstract][Full Text] [Related]
7. Declining hepatitis A antibody seroprevalence in the Korean military personnel. Lee CS; Kwon KS; Koh DH; Youm JH; Gwack J; Lee JH Jpn J Infect Dis; 2010 May; 63(3):192-4. PubMed ID: 20495272 [TBL] [Abstract][Full Text] [Related]
8. Nationwide Seropositivity of Hepatitis A in Republic of Korea from 2005 to 2014, before and after the Outbreak Peak in 2009. Kim KA; Lee A; Ki M; Jeong SH PLoS One; 2017; 12(1):e0170432. PubMed ID: 28099530 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis A virus seroprevalence in South Africa - Estimates using routine laboratory data, 2005-2015. Haeri Mazanderani A; Motaze NV; McCarthy K; Suchard M; du Plessis NM PLoS One; 2019; 14(6):e0216033. PubMed ID: 31242191 [TBL] [Abstract][Full Text] [Related]
10. Seroprevalence and disease burden of acute hepatitis A in adult population in South Korea. Yoon JG; Choi MJ; Yoon JW; Noh JY; Song JY; Cheong HJ; Kim WJ PLoS One; 2017; 12(10):e0186257. PubMed ID: 29065115 [TBL] [Abstract][Full Text] [Related]
11. Incidence and seroprevalence of hepatitis A virus infections among young Korean soldiers. Kang CI; Choi CM; Park TS; Lee DJ; Oh MD; Choe KW J Korean Med Sci; 2007 Jun; 22(3):546-8. PubMed ID: 17596668 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis A seroprevalence in patients with chronic viral hepatitis in Konya, Turkey. Özden HT Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):333-7. PubMed ID: 26703930 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis A Seroprevalence in Mogadishu, Somalia. Akbulut UE; Arslan E J Trop Pediatr; 2022 Jan; 68(1):. PubMed ID: 35134249 [TBL] [Abstract][Full Text] [Related]
14. Laboratory characteristics of recent hepatitis A in Korea: ongoing epidemiological shift. Moon HW; Cho JH; Hur M; Yun YM; Choe WH; Kwon SY; Lee CH World J Gastroenterol; 2010 Mar; 16(9):1115-8. PubMed ID: 20205283 [TBL] [Abstract][Full Text] [Related]
15. Anti-hepatitis A virus seroprevalence among patients with chronic viral liver disease in Korea. Kim DY; Ahn SH; Lee HW; Kim SU; Kim JK; Paik YH; Lee KS; Han KH; Chon CY Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):923-6. PubMed ID: 18049159 [TBL] [Abstract][Full Text] [Related]
16. Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan. Lee YL; Lin KY; Cheng CY; Li CW; Yang CJ; Tsai MS; Tang HJ; Lin TY; Wang NC; Lee YC; Lin SP; Huang YS; Sun HY; Zhang JY; Ko WC; Cheng SH; Lee YT; Liu CE; Hung CC; PLoS One; 2017; 12(10):e0186338. PubMed ID: 29036227 [TBL] [Abstract][Full Text] [Related]
17. [An epidemiological analysis of hepatitis A virus serologic markers during the recent four years in Korea]. Lee A; Lim HS; Nam CM; Song SM; Yoon HR; Lee KR Korean J Lab Med; 2009 Dec; 29(6):563-9. PubMed ID: 20046089 [TBL] [Abstract][Full Text] [Related]
18. Factors associated with anti-hepatitis A virus immunoglobulin G seropositivity among Korean workers: a cross-sectional study. Mun E; Lee Y; Suh B; Kim W; Jeong J; Park H; Lee W; Han B; Park S; Lee C BMJ Open; 2020 Jun; 10(6):e036727. PubMed ID: 32513893 [TBL] [Abstract][Full Text] [Related]
19. Seroepidemiology of hepatitis a in South Korea: a nationwide study by the Eone Reference Laboratory. Cho SE; Kim Y J Epidemiol; 2013; 23(4):270-4. PubMed ID: 23629647 [TBL] [Abstract][Full Text] [Related]
20. Immunity to Hepatitis-A virus: A nationwide population-based seroprevalence study from Iran. Lankarani KB; Honarvar B; Molavi Vardanjani H; Kharmandar A; Gouya MM; Zahraei SM; Baneshi MR; Ali-Akbarpour M; Kazemi M; Seif M; Fard SAZ; Emami A Vaccine; 2020 Oct; 38(45):7100-7107. PubMed ID: 32917416 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]